Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Breast Neoplasms 67Prostatic Neoplasms 49Multiple Myeloma 29Neoplasm Metastasis 27Osteoporosis 16Pain 15Carcinoma, Non-Small-Cell Lung 10Neoplasms 9Lung Neoplasms 8Osteosarcoma 7Neoplasms, Plasma Cell 7Neuroblastoma 6Carcinoma, Renal Cell 6Bone Diseases, Metabolic 6Humoral Hypercalcemia Of Malignancy 5Bone Neoplasms 5Fractures, Bone 4Bone Diseases 4Sarcoma, Ewing 3Sarcoma 3Lymphoma 3Kidney Neoplasms 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Spinal Cord Compression 2Small Cell Lung Carcinoma 2Rhabdomyosarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pleural Effusion, Malignant 2Ovarian Neoplasms 2

Interventions

Lenalidomide 4Gemcitabine 4Dexamethasone 4Cyclophosphamide 4Bortezomib 4Nivolumab 3Cisplatin 3Carboplatin 3vandetanib 2tumor necrosis factor-alpha, CNGRC fusion protein, human 2pomalidomide 2pembrolizumab 2liposomal doxorubicin 2fludarabine 2durvalumab 2capivasertib 2Paclitaxel 2Doxorubicin 2Bevacizumab 2venetoclax 1umbralisib 1ublituximab 1tremelimumab 1tivozanib 1ricolinostat 1regorafenib 1pazopanib 1niraparib 1nilotinib 1neratinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Disease Progression × Zoledronic Acid × Clear all
NCT00171925 2012-04-11

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I

Novartis

Phase 3 Terminated
143 enrolled 10 charts
Plasma cell

Multiple Myeloma, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡